Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

NCT01319669 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped recruiting too slowly

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: recombinant human thrombopoietin

Sponsor

Chinese Society of Lung Cancer